US5114719A
(en)
*
|
1987-04-29 |
1992-05-19 |
Sabel Bernhard A |
Extended drug delivery of small, water-soluble molecules
|
US5156164A
(en)
*
|
1988-10-13 |
1992-10-20 |
Leveen Harry H |
Iodine contraceptive sponge
|
BE1002600A3
(fr)
*
|
1988-11-23 |
1991-04-09 |
Wildemeersch Dirk |
Dispositif intra-uterin perfectionne.
|
IE71202B1
(en)
*
|
1990-12-17 |
1997-02-12 |
Akzo Nv |
Progestagen-only contraceptive
|
WO1993017662A1
(en)
*
|
1992-03-02 |
1993-09-16 |
Daratech Pty. Ltd. |
Improved implants
|
ES2150427T3
(es)
*
|
1992-06-02 |
2000-12-01 |
Bard Inc C R |
Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
|
US5368588A
(en)
*
|
1993-02-26 |
1994-11-29 |
Bettinger; David S. |
Parenteral fluid medication reservoir pump
|
US5443461A
(en)
*
|
1993-08-31 |
1995-08-22 |
Alza Corporation |
Segmented device for simultaneous delivery of multiple beneficial agents
|
US5681817A
(en)
|
1994-02-04 |
1997-10-28 |
The Medical College Of Hampton Roads |
Treatment of ovarian estrogen dependent conditions
|
US5660848A
(en)
*
|
1994-11-02 |
1997-08-26 |
The Population Council, Center For Biomedical Research |
Subdermally implantable device
|
US5521166A
(en)
*
|
1994-12-19 |
1996-05-28 |
Ortho Pharmaceitical Corporation |
Antiprogestin cyclophasic hormonal regimen
|
DE19539361A1
(de)
*
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
US5733565A
(en)
*
|
1996-02-23 |
1998-03-31 |
The Population Council, Center For Biomedical Research |
Male contraceptive implant
|
CN1088993C
(zh)
*
|
1996-10-11 |
2002-08-14 |
上海市计划生育科学研究所 |
含孕二烯酮的长效皮下避孕埋植剂
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
TW358031B
(en)
*
|
1997-04-11 |
1999-05-11 |
Akze Nobel N V |
Drug delivery system for 2 or more active substances
|
DE19744135C1
(de)
*
|
1997-09-29 |
1999-03-25 |
Schering Ag |
Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
US6394094B1
(en)
|
1998-05-01 |
2002-05-28 |
Enhance Pharmaceuticals, Inc. |
Method for injection molding manufacture of controlled release devices
|
US6117441A
(en)
*
|
1998-07-02 |
2000-09-12 |
The Population Council, Inc. |
Silicone core long term androgen delivery implant
|
EP1098653A2
(en)
*
|
1998-07-17 |
2001-05-16 |
PHARMACIA & UPJOHN COMPANY |
Subcutaneous medroxyprogesterone acetate for contraception
|
US6117442A
(en)
*
|
1998-11-12 |
2000-09-12 |
Leiras Oy |
Drug delivery device, especially for the delivery of androgens
|
US6063395A
(en)
*
|
1998-11-12 |
2000-05-16 |
Leiras Oy |
Drug delivery device especially for the delivery of progestins and estrogens
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
CA2267743C
(en)
*
|
1999-03-30 |
2011-07-26 |
Robert F. Casper |
Low dose estrogen interrupted hormone replacement therapy
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
DK1313511T3
(da)
*
|
2000-08-23 |
2006-03-20 |
Akzo Nobel Nv |
Testosteronesterformulering til human brug
|
JP2006500115A
(ja)
|
2000-11-16 |
2006-01-05 |
マイクロスフエリツクス・エル・エル・シー |
密封小線源治療用の可撓性および/または弾性シードまたはストランド
|
JP4866535B2
(ja)
|
2001-05-11 |
2012-02-01 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
動物で用いるに適した免疫調節用デバイス
|
ATE319451T1
(de)
|
2001-07-02 |
2006-03-15 |
Akzo Nobel Nv |
Tetrahydrochinolin-derivate
|
WO2003017971A1
(en)
*
|
2001-08-31 |
2003-03-06 |
Schering Oy |
Drug delivery system
|
WO2003020727A1
(en)
|
2001-09-04 |
2003-03-13 |
Akzo Nobel N.V. |
GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
|
TWI228508B
(en)
|
2001-09-04 |
2005-03-01 |
Akzo Nobel Nv |
Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
|
AU2003201410B2
(en)
*
|
2002-01-24 |
2008-07-03 |
Virbac Corporation |
Sustained release pharmaceutical composition
|
CN1652799A
(zh)
*
|
2002-03-11 |
2005-08-10 |
詹森药业有限公司 |
只用抑制硫酸酯酶的孕激素的避孕给药方案
|
TWI297685B
(en)
|
2002-04-04 |
2008-06-11 |
Organon Nv |
Non-steroidal progesterone receptor modulators
|
AU2003234439A1
(en)
*
|
2002-05-07 |
2003-11-11 |
Control Delivery Systems, Inc. |
Processes for forming a drug delivery device
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7736665B2
(en)
*
|
2002-05-31 |
2010-06-15 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of buprenorphine
|
RU2340345C2
(ru)
*
|
2002-08-28 |
2008-12-10 |
Роберт КАСПЕР |
Схема восполнения эстрогена
|
US7795280B2
(en)
|
2002-11-07 |
2010-09-14 |
N.V. Organon |
Indoles useful in the treatment of androgen-receptor related diseases
|
TWI306855B
(en)
|
2002-12-20 |
2009-03-01 |
Organon Nv |
Tetrahydroquinoline derivatives
|
TWI322012B
(en)
|
2002-12-20 |
2010-03-21 |
Organon Nv |
Tetrahydroquinoline derivatives
|
KR101152183B1
(ko)
|
2003-03-31 |
2012-06-15 |
타이탄 파머슈티컬즈 인코퍼레이티드 |
도파민 아고니스트의 지속 방출을 위한 이식가능한 폴리머디바이스
|
EP1620060B1
(en)
|
2003-04-29 |
2010-03-24 |
The General Hospital Corporation |
Methods and devices for the sustained release of multiple drugs
|
TWI336627B
(en)
|
2003-05-23 |
2011-02-01 |
Organon Nv |
Drug delivery system,and use and manufacturing method thereof
|
JP2007502866A
(ja)
*
|
2003-05-30 |
2007-02-15 |
タイタン ファーマシューティカルズ インコーポレイテッド |
ナルメフェンの持続的放出のための移植可能ポリマー装置
|
EP1643946A2
(en)
*
|
2003-06-20 |
2006-04-12 |
Viral Genomix, Inc. |
Compositions for and methods for treating hiv
|
CA2552757A1
(en)
*
|
2004-01-13 |
2005-08-04 |
Vasogenix Pharmaceuticals, Inc. |
Methods of using cgrp for cardiovascular and renal indications
|
EP1703916A2
(en)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
|
CA2552677A1
(en)
*
|
2004-01-13 |
2005-07-28 |
Vasogenix Pharmaceuticals, Inc. |
Controlled release cgrp delivery composition for cardiovascular and renal indications
|
TWI434676B
(zh)
|
2004-03-19 |
2014-04-21 |
Merck Sharp & Dohme |
可用x射線看出之藥物遞送裝置
|
TW200531977A
(en)
|
2004-03-25 |
2005-10-01 |
Akzo Nobel Nv |
Progesterone receptor modulators
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
PT1629844E
(pt)
†
|
2004-07-13 |
2007-10-17 |
Bayer Schering Pharma Oy |
Sistema de distribuição a longo prazo com distribuição súbita inicial controlada
|
CA2575988C
(en)
|
2004-08-04 |
2014-02-18 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US8394840B2
(en)
*
|
2005-06-15 |
2013-03-12 |
Hydra Biosciences, Inc. |
Modulators of sperm hypermotility and uses thereof
|
EP1743638A1
(en)
|
2005-07-15 |
2007-01-17 |
Laboratorios Del Dr. Esteve, S.A. |
Pharmaceutical formulations of substituted pyrazoline compounds
|
DK2049081T3
(da)
|
2006-08-09 |
2013-02-25 |
Intarcia Therapeutics Inc |
Osmotiske leveringssystemer og stempelarrangementer
|
US7989442B2
(en)
|
2006-09-27 |
2011-08-02 |
N.V. Organon |
Progesterone receptor modulators
|
CN101209238B
(zh)
*
|
2006-12-27 |
2012-05-09 |
辽宁省计划生育科学研究院 |
含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备
|
PT2157967E
(pt)
|
2007-04-23 |
2013-04-03 |
Intarcia Therapeutics Inc |
Formulações de suspensões de péptidos insulinotrópicos e suas utilizações
|
US8063037B2
(en)
|
2007-05-07 |
2011-11-22 |
N. V. Organon |
Progesterone receptor modulators
|
CN101130057B
(zh)
*
|
2007-07-06 |
2011-04-27 |
复旦大学 |
胸腺五肽长效植入剂及其制备方法
|
TW200930343A
(en)
|
2007-09-21 |
2009-07-16 |
Organon Nv |
Drug delivery system
|
EP2227252B1
(en)
|
2007-11-27 |
2012-07-25 |
Nira Hochman |
Adjuvant comprising vaccinium macrocarpon
|
EP2222281B1
(en)
|
2007-12-20 |
2018-12-05 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
KR102148624B1
(ko)
|
2009-09-28 |
2020-08-26 |
인타르시아 세라퓨틱스 인코포레이티드 |
실질 항정상태 약물 전달의 신속 확립 및/또는 종결
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US10028858B2
(en)
|
2011-07-11 |
2018-07-24 |
Medicines360 |
Intrauterine systems, IUD insertion devices, and related methods and kits therefor
|
AR089765A1
(es)
*
|
2012-01-23 |
2014-09-17 |
Bayer Oy |
Un sistema para el suministro de un farmaco
|
EP2953678B1
(en)
|
2013-02-06 |
2020-03-25 |
Sillender, Mark |
Therapeutic substance transfer catheter
|
US10188426B2
(en)
|
2013-02-06 |
2019-01-29 |
Mark SILLENDER |
Embryo transfer catheter and method
|
US10413504B2
(en)
|
2013-12-11 |
2019-09-17 |
Merck Sharp & Dohme Corp. |
Intravaginal ring drug delivery system
|
US10596103B2
(en)
|
2013-12-11 |
2020-03-24 |
Merek Sharp & Dohme B.V. |
Drug delivery system for delivery of anti-virals
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
WO2016149561A1
(en)
*
|
2015-03-17 |
2016-09-22 |
Oak Crest Institute Of Science |
Subdermal implants for the sustained delivery of water-soluble drugs
|
KR20240042548A
(ko)
|
2015-06-03 |
2024-04-02 |
인타르시아 세라퓨틱스 인코포레이티드 |
임플란트 배치 및 제거 시스템들
|
CN109310743A
(zh)
|
2016-05-16 |
2019-02-05 |
因塔西亚制药公司 |
胰高血糖素受体选择性多肽及其使用方法
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
US9980850B2
(en)
|
2016-09-29 |
2018-05-29 |
Gesea Biosciences, Inc. |
Bioerodible contraceptive implant and methods of use thereof
|
KR20190104039A
(ko)
|
2017-01-03 |
2019-09-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
|
US11571328B2
(en)
|
2018-04-09 |
2023-02-07 |
Medicines360 |
IUD insertion devices
|
MX2020012458A
(es)
|
2018-05-24 |
2021-04-28 |
Celanese Eva Performance Polymers Llc |
Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
|
CN111989068A
(zh)
|
2018-05-24 |
2020-11-24 |
塞拉尼斯伊娃高性能聚合物公司 |
用于持续释放大分子药物化合物的可植入器件
|
US20200261258A1
(en)
|
2019-02-19 |
2020-08-20 |
Medicines360 |
Devices, systems, methods and kits for insertion and removal of iuds
|
BR102020007749A2
(pt)
|
2020-04-17 |
2021-11-03 |
Edson Luiz Peracchi |
Implante subcutâneo reabsorvível de longa duração com liberação controlada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da endometriose
|
BR102020010923A2
(pt)
|
2020-05-29 |
2021-12-14 |
Luiz Peracchi Edson |
Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da insuficiência adrenal crônica ou hipocortisolismo
|
BR102020013862A2
(pt)
|
2020-07-07 |
2022-01-18 |
Edson Luiz Peracchi |
Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson
|
WO2022204771A1
(pt)
|
2021-03-29 |
2022-10-06 |
Edson Luiz Peracchi |
Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento do hipotireoidismo e processo
|
CN113209050A
(zh)
*
|
2021-05-14 |
2021-08-06 |
浙江恒冀制药有限责任公司 |
基于生物相容性聚合物的长效体内皮埋或内植缓释制剂
|
GB202401392D0
(en)
|
2024-02-02 |
2024-03-20 |
Imphatec Ltd |
Implant for delivery of a drug
|